Bionano Genomics
BNGO
108 hedge funds and large institutions have $32.1M invested in Bionano Genomics in 2023 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 19 increasing their positions, 36 reducing their positions, and 45 closing their positions.
0.02% less ownership
Funds ownership: 0.04% → 0.03% (-0.02%)
14% less funds holding
Funds holding: 126 → 108 (-18)
27% less call options, than puts
Call options by funds: $525K | Put options by funds: $719K
38% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 45
47% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 36
65% less capital invested
Capital invested by funds: $90.6M → $32.1M (-$58.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.96M |
| 2 |
Millennium Management
New York
|
+$2.51M |
| 3 |
Mitsubishi UFJ Asset Management
Tokyo,
Japan
|
+$1.91M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$415K |
| 5 |
CF
Cantor Fitzgerald
New York
|
+$376K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$12.9M |
| 2 |
State Street
Boston,
Massachusetts
|
-$5.16M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.11M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.93M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.55M |
BNGO Hedge Fund Activity: Q2 2023 in Review
108 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q2 2023, worth a combined $32.1M — down 65% from $90.6M a quarter earlier.
Sellers outnumbered buyers: 45 funds closed out of BNGO and 28 opened new positions — a net loss of 17 holders — while 36 trimmed existing stakes and 19 added.
The largest buyer was Qube Research & Technologies (QRT), opening a new position worth an estimated $2.96M. The largest seller was BlackRock, cutting an estimated $12.9M.
- 108 institutional investors held Bionano Genomics (BNGO) as of Q2 2023, down from 126 in Q1 2023.
- Funds reported $32.1M of Bionano Genomics stock for Q2 2023, down 65% quarter-over-quarter.
- 28 funds opened new Bionano Genomics positions in Q2 2023 and 45 closed out, a net change of -17 holders.
- The largest Bionano Genomics buyer in Q2 2023 was Qube Research & Technologies (QRT), an estimated $2.96M added.
- The largest Bionano Genomics seller in Q2 2023 was BlackRock, an estimated $12.9M sold.
Based on aggregated 13F filings for Q2 2023.